Stay updated on Oral Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check2 days agoChange DetectedThe study record was updated to revision v3.5.4, indicating a newer version of the entry in ClinicalTrials.gov. This appears to be an administrative update rather than a substantive change to the study content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3 on the page, indicating a minor maintenance update to the page's record. This reflects an incremental revision in the underlying versioning rather than changes to study data or visible content.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page's revision label changed from v3.5.0 to v3.5.2. This appears to be a backend/UI update with no impact on the study details presented.SummaryDifference0.1%

- Check59 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check66 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be an administrative update with no changes to study content or user workflow.SummaryDifference0.1%

- Check95 days agoChange DetectedAdministrative site updates were made: the page shows Revision: v3.4.2 and the operating-status notice about government funding lapse was removed, along with the prior Revision: v3.4.1 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Oral Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Upadacitinib in Atopic Dermatitis Clinical Trial page.